c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. - Wikidata - wikimedia - TriplyDB

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

http://www.wikidata.org/entity/Q36238451

about

A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformation MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis USP10 regulates p53 localization and stability by deubiquitinating p53 Lactate dehydrogenase is an AU-rich element-binding protein that directly interacts with AUF1 Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer A novel heterodimerization domain, CRM1, and 14-3-3 control subcellular localization of the MondoA-Mlx heterocomplex.The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis Links between metabolism and cancer Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1 Hypoxia and oxidative stress in breast cancer. Hypoxia signalling pathways Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays.Targeting Cancer Metabolism - Revisiting the Warburg Effects Fundamentals of cancer metabolism Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect The sweet trap in tumors: aerobic glycolysis and potential targets for therapy Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism MYC, Metabolism, and Cancer Dysregulated metabolism contributes to oncogenesis Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy Cancer metabolism: key players in metabolic reprogramming Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy Is cancer a metabolic disease?Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments Autophagy: a targetable linchpin of cancer cell metabolism Novel therapeutic targets of tumor metabolism P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy The Caenorhabditis elegans Myc-Mondo/Mad complexes integrate diverse longevity signals Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition Oncometabolites: Unconventional triggers of oncogenic signalling cascades Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect Adipose tissue dysfunction and its effects on tumor metabolism

P2860

Q24291788-A5B9E9B1-6FF4-47C7-85F3-0F802554793B Q24294199-BE8553ED-8BA0-4449-90AB-B187297BE0BB Q24296967-5EFC8DD1-3FEE-4955-80DA-CB7A955ECBE0 Q24301095-912DE806-01CD-4FFA-8B0B-95438B355C78 Q24320179-182C3C0E-0629-4506-8286-D220C328E090 Q24336084-B86CB290-1237-43DF-99E9-D3416C7BE268 Q24337240-7DB5AC73-17F0-47B9-BA47-5F94BC0406C6 Q24540211-86C521B1-51C0-45E5-A50A-45E6C00AE24A Q24613186-31CF2BE0-E30A-43FB-8AE8-5C184C9D352E Q24626229-07DF83CE-FB0B-4F78-B6E9-1691A9CBE51A Q24681460-30CEEEB8-9D3A-4606-8786-87431BFB8123 Q24801701-CD0B9128-5555-4DFF-90DF-6808677F62E8 Q24810339-1F4A9631-472B-4A80-9F7A-60B3BCD3AEBB Q26738876-BEFB6737-DF8A-433F-9961-A3229E968851 Q26744062-3F519723-EAC6-437E-A31A-8259BBA79199 Q26745461-4D907B67-7EBA-40D6-A654-93FA148D91F8 Q26766079-91FB948A-55E2-4E3B-B1E2-BD7A5FC98909 Q26766711-278E9FC9-2424-4006-BE96-BD21E20F2C67 Q26778362-4C1CE2F2-7F56-4573-A56B-776863418541 Q26783555-2EB4F2C9-7028-4FCA-A8D6-DD8E342C80C9 Q26784630-9BB3D7D1-720F-49F1-BFDD-842F729C8799 Q26798253-96FC4723-BEAE-48E7-8EFA-5707C57082F0 Q26827663-B58024F2-D2B6-4028-90E2-26526EF550E1 Q26851585-C03308E0-2A81-4A2E-B944-10A1116B5E31 Q26852241-26D1AAA1-1A0F-4935-B449-1E627B1296F7 Q26852282-38D3BFC2-47E7-4CDD-8A54-C00EB3495934 Q26853482-C3CE6B06-85A0-46EA-AC89-B302F6DCA941 Q26853567-816E4013-79BC-4921-BC32-9F0AE591D2A3 Q26863243-4B0FCA30-271F-4232-A77D-49CBD2EF8391 Q27004020-CEE561AA-3FB2-4A3E-8107-6F73E7A234DE Q27005930-833BA4DB-0425-428C-A97A-13739E132D64 Q27011547-53BDB0FC-49B6-4742-BEE1-0CE5F920F06C Q27316318-8B929C7A-6A7A-4779-9371-7194DBE636C7 Q27723745-30F52608-4900-498C-91FA-217642B5CB44 Q28069594-48EE5150-68E1-4045-8AB4-84BC898298F4 Q28072669-4A3AB8A2-F7E4-4629-A581-D9F95CFF8A3B Q28073524-82524BF3-DBA4-4734-A628-3B5770CEB37B Q28076454-E0B3F37D-1CEB-4006-BC4D-E443ADAFA50F Q28077883-CF5C4714-96E2-4C27-9334-BE3AB977F7D1 Q28080748-F7703EB3-DC1A-45D6-B666-E216B8F50EB5

P2860

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

http://www.wikidata.org/entity/Q36238451

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@ast

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@en

type

label

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@ast

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@en

prefLabel

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@ast

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@en

P1433

Q36238451-429F198F-EB4E-488B-9E3D-5F9FCA708218

P1476

Q36238451-877C4143-E08A-44B6-A2C4-40790DCA1DE1

P2093

Q36238451-080B489F-9724-4279-91B6-68B1D5F587C7

Q36238451-2A47DA10-10FB-45BD-B7DB-60DCDE75C7F8

Q36238451-4F488CAB-8847-4A1B-B940-F7A6BA128A99

Q36238451-501B7899-1CB2-437B-8D58-F5EAEA59AEB3

Q36238451-54F99CF3-4644-40C8-BB24-EE1E72295F87

Q36238451-91C6142C-0D6E-4445-9FE3-A2B5CB620996

Q36238451-B07992C9-10C5-4BEC-9917-7105D2A9CB04

Q36238451-C433BA53-1BED-42FA-AAD0-C193C6181D42

P2860

Q36238451-00696CB0-D4B3-4D3F-88D4-62508CD4FD9E

Q36238451-0ABF45EB-4255-4A5C-8F2F-5E927D0787EB

Q36238451-0B2F8ADB-DA14-4636-8C66-A1A881D3B9FD

Q36238451-118C7738-F26F-481B-A4C2-7F0D0ED99C18

Q36238451-25DC020A-DDC9-4CFE-800F-A53CD98C77C1

Q36238451-26D3273F-C3B0-457E-BDEC-C057C41DA716

Q36238451-2B27BE05-2057-4FC2-92CE-F33B7A25C37C

Q36238451-2FAD8970-8EFE-4340-B60B-CC9BA12D2B23

Q36238451-3362D75F-971A-45C8-839B-3B1787862209

Q36238451-36502BDF-AF69-4AC8-BD7E-D330547A2649

P304

Q36238451-DB5ECCDD-C11B-476C-911A-E7C03DAFB4E3

P31

Q36238451-AAF136A0-8C48-43E9-B354-7E6806C77202

P356

Q36238451-05321FC2-55DD-4539-9FE0-6DACE2B55375

P407

Q36238451-DD003DC7-12E6-42EC-AE5D-B0F981A1AFA8

P433

Q36238451-106EFF22-8A0A-43AE-BB48-BF8AC30DEAB0

P478

Q36238451-56DF6A08-0172-4070-8B5C-7B8878F4C06F

P577

Q36238451-77523CEB-BFE0-4EE3-8EFC-095F7BAB3314

P5875

Q36238451-8F53FD74-29F6-4D03-B8CA-0424993D6887

P698

Q36238451-8127B41F-736A-40EE-BD92-BC2885D98981

P932

Q36238451-10788962-2A0A-489C-ADBA-AE766EC5957E

P356

PNAS.94.13.6658

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth.

@en

P2093

B C Lewis

http://www.w3.org/2001/XMLSchema#string

C Dolde

http://www.w3.org/2001/XMLSchema#string

C S Wu

http://www.w3.org/2001/XMLSchema#string

C V Dang

http://www.w3.org/2001/XMLSchema#string

G Dang

http://www.w3.org/2001/XMLSchema#string

H Shim

http://www.w3.org/2001/XMLSchema#string

R A Jungmann

http://www.w3.org/2001/XMLSchema#string

R Dalla-Favera

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

ECA39, a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation in yeast

The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer

Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo

The ornithine decarboxylase gene is a transcriptional target of c-Myc

Transcriptional activation by Myc is under negative control by the transcription factor AP-2

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product

On the Origin of Cancer Cells

P304

6658-6663

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.13.6658

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235607323

http://www.w3.org/2001/XMLSchema#string

P698

9192621

http://www.w3.org/2001/XMLSchema#string

P932

21214

http://www.w3.org/2001/XMLSchema#string